Plasma Levels of hsa-miR-619-5p and hsa-miR-1184 Differ in Prostatic Benign Hyperplasia and Cancer

E. N. Knyazev; K. A. Fomicheva; D. S. Mikhailenko; K. M. Nyushko; T. R. Samatov; B. Ya. Alekseev; M. Yu. Shkurnikov

doi:10.1007/s10517-016-3357-7

Plasma Levels of hsa-miR-619-5p and hsa-miR-1184 Differ in Prostatic Benign Hyperplasia and Cancer

Авторы: Knyazev E.N.¹, Fomicheva K.A.², Mikhailenko D.S.², Nyushko K.M.², Samatov T.R.¹, Alekseev B.Y.², Shkurnikov M.Y.¹^,2
Учреждения:
1. BioClinicum Center Research and Development Company
2. Medical Radiology Center
Выпуск: Том 161, № 1 (2016)
Страницы: 108-111
Раздел: Article
URL: https://journals.rcsi.science/0007-4888/article/view/237158
DOI: https://doi.org/10.1007/s10517-016-3357-7
ID: 237158

Цитировать

Полный текст

Открытый доступ
Доступ закрыт

Доступ предоставлен
Доступ закрыт

Только для подписчиков

Аннотация
Об авторах
Список литературы
Дополнительные файлы
Статистика

Аннотация

Peripheral blood plasma profiles of circulating microRNA expression were analyzed in patients with prostatic cancer and benign hyperplasia. In prostatic cancer, significant increase in hsa-miR-619-5p and hsa-miR-1184 microRNA expression and significant decrease in hsalet-7b-5p and hsa-let-7c-5p microRNA expression were observed. The role of the relationship between the microRNA expression and the activities and functions of host genes with introns encoding these microRNA is discussed.